Hints and tips:
Related Special Reports
...The FDA’s approval includes Casgevy and Bluebird Bio’s therapy called Lyfgenia. The drug could be used to replace bone marrow transplants....
...The US list price of the treatment is $2.2mn per dose, while Lyfgenia, another gene therapy for sickle cell disease developed by Bluebird Bio and approved on the same day as Casgevy, costs $3.1mn per dose...
...employ other methods to identify underage users, including human moderators and artificial intelligence detection of language that might suggest they are under 18, for example writing their age in their bio...
...A shrinking domestic market is forcing Japan Inc to look for growth overseas. Ultra-low interest rates back home have further whetted the appetite for deals....
...In the Swiss ski resort of Crans-Montana winter came early with a fortnight of cloudless cobalt skies above a fresh dump of snow — the best kind of “bluebird” days on the slopes, in US ski parlance....
...Alongside this, bio-brands are launching with increasing regularity....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...Other commercial partners have also cut ties with him, including his publisher Bluebird, an imprint of Pan Macmillan, which was due to bring out a book in December, and the Curtis Brown-owned talent agency...
...UK-based Meatless Farm laid off its staff in June and appointed administrators after its big shareholder SK Inc, the investment arm of South Korean conglomerate SK Group, pulled funding....
...Last year Bluebird Bio withdrew Zynteglo, a one-time gene therapy for the blood disorder beta thalassaemia, from the European market after failing to persuade governments to cover its $1.8mn price tag....
...Earlier on Monday, French pharmaceutical company Sanofi struck a deal to buy Type-1 diabetes treatment developer Provention Bio for $2.9bn, in a bid to bolster its drug pipeline after facing pressure from...
...Last year, Boston-based Bluebird Bio pulled Zynteglo, its one-off gene therapy for the blood disorder beta thalassaemia, from the European market after failing to persuade the German government to cover...
...A link under her bio brings interested users to the DH Gate website, where they can buy the same products....
...Platforms’ current checks involve asking users for their date of birth and scanning text in comments, captions and bios for anything that may indicate an age....
...This week there was some good news for gene therapies when Bluebird Bio’s treatment for beta-thalassemia received FDA approval....
...Boyle’s bio-series is never less than compelling — the story of the group’s deranged formation is simply inconceivable in the X Factor era — and full of witty moments....
...This is the practice of signalling your support for the moral cause du jour by, for instance, adding a flag emoji or hashtag to your Twitter bio, while doing nothing to help that cause in the real world....
...Watching Sky Atlantic’s delightful new bio-series Julia, you can forget that you’re seeing someone act. Lancashire doesn’t so much perform here as disappear....
...In her bio, she calls herself Chief Excel Officer. Norton says the videos that perform best are the ones that cover core Excel functions, like flash fill and keyboard shortcuts....
...As his TikTok bio reads: “What would I do if I won the lottery? Keep farming until the money ran out!” The sector could do with a bit more of his youthful vigour....
...Another biotech, Bluebird Bio, which has made accessibility and affordability of genomic therapeutics a cornerstone of its business, isn’t rated by MSCI ESG at all, so owning that would lower an average...
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
...And Linktree, a “link in bio” service, created an integration with Shopify storefronts....
...In addition to her regular columns for Forbes she also wrote for Inc magazine on topics ranging from leadership skills to “snake handling techniques to help you deal with stress”....
...Triomphe believes the company is well placed to succeed: it bought mRNA start-up Translate Bio for $3bn earlier this year, and has promised to plough €400m a year into mRNA vaccine research with 400 scientists...
International Edition